- Little Green Pharma (LGP) has received firm commitments to undertake a $22 million placement
- All up, 34 million new fully-paid ordinary shares will be issued to investors at 65 cents
- This price represents a 30.5 per cent discount on LGP’s trading price of 93.5 cents on February 4
- LGP is also planning to undertake a share purchase plan to raise up to $5 million
- Eligible shareholders will able to subscribe for up to $30,000 worth of shares without incurring any brokerage or transmission costs
- LGP will use the money to speed-up sales and marking efforts in both Australia and overseas, and expand its manufacturing and cultivation capacity
